...and finally a post again ;)
$SREN (-2.57%) is a new addition - for me a solid anchor with a stable dividend base and global positioning. Exactly the kind of stock that pays very good dividends in a long-term portfolio.
I have also further increased my position in $CV also increased my position further 🚀
CapsoVision is active in the MedTech sector and develops innovative solutions for endoscopic diagnostics. The market it addresses is huge - at the same time, the company is still relatively unknown and therefore clearly a growth story in my view.
What particularly appeals to me:
- Niche focus with a technological USP
- Scaling potential in the international healthcare market
- Opportunity to establish itself in a specialized segment
- Still under the radar of many investors
Of course, this is not a "safe dividend play", but rather an opportunity-oriented growth case with a higher risk. This is precisely why I currently find the mix of defensive (Swiss Re) and offensive (CapsoVision) exciting.
I would be interested in your opinion:
Do you see real multibagger potential in CapsoVision or is the risk here too high for you?
And who of you is also invested there (Swiss Re, CapsoVision)?
Have a nice Sunday. :)
#swissre
#wachstumsaktien
#medtech
#smallcaps
#aktien
#aktienanalyse
#langfristiginvestieren
#aktiencommunity
#etf
#börse
#dividende
